Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Camphor SCHEMBL31059217 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL16068 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL1151878 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL1712401 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL16582770 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL13248606 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL15542393 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| (-)-Camphor SCHEMBL1701376 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL2037672 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Camphor SCHEMBL29673264 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | claimed |
| US-12296042-B2 | Cosmetic compositions comprising silicone elastomer | CONOPCO, INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-3908250-B1 | COSMETIC COMPOSITIONS COMPRISING SILICONE ELASTOMER | UNILEVER IP HOLDINGS B V (NL) | 2025-03-26 | — | — | EP | claimed |
| US-20240327418-A1 | MULTI-TARGET INHIBITOR TARGETING HDAC AND NAD SYNTHESIS AND USE OF MULTI-TARGET INHIBITOR | OCEAN UNIVERSITY OF CHINA (CN) | 2024-10-03 | — | — | US | claimed |
| CN-118638123-A | Camphor inner sulfonamide reversible phase change material and preparation method thereof | 南昌大学 | 2024-09-13 | — | — | CN | claimed |
| US-20240215608-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2024-07-04 | — | — | US | claimed |
| EP-4319559-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | Eastman Chemical Company (US) | 2024-02-14 | — | — | EP | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2022217031-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | WO | claimed |
| EP-4040979-A1 | ANTIMICROBIAL COMPOSITION FOR ANIMAL FEED | Taminco BV (BE) | 2022-08-17 | — | — | EP | claimed |
| US-20220079869-A1 | COSMETIC COMPOSITIONS COMPRISING SILICONE ELASTOMER | CONOPCO, INC., D/B/A UNILEVER (US) | 2022-03-17 | — | — | US | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-14 | — | — | US | disclosed |
| CN-120713838-B | Medicinal injection and preparation method thereof | 广东粤和泽药物研究有限公司 | 2026-03-03 | — | — | CN | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| CN-1846758-A | Hypoglycemic medicine for treating diabetes and its prepn process | RENMIN HOSPITAL YIAGCHENG HUBE (CN) | 2006-10-18 | — | — | CN | disclosed |
| US-5268492-A | Optically active diphosphines, intermediates thereof, and processes for production thereof | MITSUI TOATSU CHEMICALS, INC. (JP) | 1993-12-07 | — | — | US | disclosed |
| EP-0530015-A1 | Optically active diphosphines, intermediates thereof, and processes for production thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12296042-B2 | Cosmetic compositions comprising silicone elastomer | CUTA, ERCC1, MMS19 | ALDH1A1 230/4885KMT2A 1645/4885MEN1 660/4885 |
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | F2, C9, S100A8 | ALDH1A1 2233/4885KMT2A 3763/4885MEN1 3507/4885 |
| US-20220079869-A1 | COSMETIC COMPOSITIONS COMPRISING SILICONE ELASTOMER | CUTA, ERCC1, MMS19 | ALDH1A1 230/4885KMT2A 1645/4885MEN1 660/4885 |
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | FABP2, FABP1, VIP | ALDH1A1 1928/4885KMT2A 3786/4885MEN1 3600/4885 |
| US-20240327418-A1 | MULTI-TARGET INHIBITOR TARGETING HDAC AND NAD SYNTHESIS AND USE OF MULTI-TARGET INHIBITOR | HDAC3, HDAC1, HDAC11 | ALDH1A1 380/4885KMT2A 138/4885MEN1 3861/4885 |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | COL2A1, COLGALT1, PLOD3 | ALDH1A1 568/4885KMT2A 1308/4885MEN1 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.